Please login to the form below
NICE Scientific Advice
This page shows the latest NICE Scientific Advice news and features for those working in and with pharma, biotech and healthcare.
Novartis first to benefit from NICE advice on ‘patient preference’
In the last financial year, NICE Scientific Advice generated £1.8m, income which makes a modest contribution to sustaining the agency, which has seen its funding cut back and its workload ... Jeanette Kusel. Jeanette Kusel, Director of NICE Scientific
Latest news
-
NICE and Canadian counterpart to offer joint advice service
Agencies offer parallel scientific advice. NICE and the Canadian Agency for Drugs and Technology in Health (CADTH) have joined forces to offer pharma a health technology assessment (HTA) service. ... We recognise the inherent difficulties faced by
-
Daily Brief: Keytruda and microbiome synergy, Pfizer's files PARP contender and more
To try and head the problem off before it gets to this stage, the Institute’s NICE Scientific Advice (NSA) division has launched a new health economic model review service, Preliminary ... Leeza Osipenko, head of NICE Scientific Advice said: “If
-
NICE tasked with speeding NHS uptake of new technology
NICE already has a scientific advice programme which provides consultancy and guidance to manufacturers and HTAP will work with, and expand on, this to provide more effective routes to implementing new ... We hope there will be a more seamless
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- Sanofi halts recruitment for trials assessing MS treatment
- Eli Lilly to make bebtelovimab commercially available to US states from August
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Powering Rapid Cognitive Analysis with AI
- How the Royal Society’s EiR programme can help to drive UK innovation
- BMS and 2seventy bio announce positive results for multiple myeloma treatment
- Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
- Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
- JCVI publishes statement on London polio vaccination strategy
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris
- EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
PMHub
foxandcat.online
We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...
